Greenland Mines Launches $50M At-the-Market Offering with A.G.P.
GRML is trading near its 52-week low of $7.815 (7.0% above the low).
Summary
Greenland Mines established a $50M at-the-market offering program with A.G.P. to sell shares over time, providing working capital amid going concern doubts and a Nasdaq delisting deadline.
Key Events · Financing and Capital Events · GRML
-
$50M ATM Program Established
Greenland Mines entered into a sales agreement with A.G.P. on August 24, 2026 to sell up to $50 million of common stock from time to time at market prices.
-
Dilution Potential
Assuming sales at $10.14 per share, shares outstanding could rise from 3,177,013 to up to 8,107,979 — an increase of roughly 155%.
-
Series C Preferred Overhang
40,800,776 shares are issuable upon conversion of Series C Preferred stock, representing a massive additional dilution source beyond the ATM program.
-
Going Concern and Nasdaq Risk
The company faces going concern doubts and a Nasdaq delisting deadline, making this ATM a critical funding source to maintain listing and operations.
Analysis · GRML · Life Sciences
Greenland Mines has entered into a $50 million at-the-market sales agreement with A.G.P./Alliance Global Partners, allowing the company to sell shares into the market from time to time. The offering comes as the company faces going concern doubts and a Nasdaq delisting deadline, making this a critical liquidity lifeline. However, the ATM structure means shares will be drip-fed into the market, creating persistent overhang on the stock. The 3.0% commission to A.G.P. is standard for ATM programs. The filing also confirms a 1-for-50 reverse stock split effective today, which was previously approved by shareholders in June.
How filings like this one have moved
In the 30 days to Aug 24, 2026, 29.4% of the 2796 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.03%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GRML was trading at $8.36 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $7.82 to $39.45. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.